Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02050321
Title A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Arizona



Acitretin + Vemurafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
*Shaded cells indicate that there was no data available from for the field